Geron Corp (NAS:GERN)
$ 4.12 -0.05 (-1.2%) Market Cap: 2.49 Bil Enterprise Value: 2.24 Bil PE Ratio: 0 PB Ratio: 8.49 GF Score: 35/100

Geron Corp Host Virtual Investor Event Call Transcript

Nov 09, 2021 / 09:00PM GMT
Release Date Price: $1.68 (-2.33%)
Olivia Kyusuk Bloom
Geron Corporation - Executive VP of Finance, CFO & Treasurer

Good afternoon, everyone. Welcome to the Geron Investor Event. I am joined today by Dr. John Scarlett, Geron's Chairman and Chief Executive Officer; Dr. Aleksandra Rizo, Geron's Executive Vice President and Chief Medical Officer; and Anil Kapur, Geron's Executive Vice President of Corporate Strategy and Chief Commercial Officer. In addition, we are honored to have present 3 key opinion leaders in hemologic (sic) [hematologic] malignancies, Dr. John Mascarenhas, Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai; Dr. Uwe Platzbecker, Director of the Medical Clinic, University Hospital, Leipzig; and Dr. Swami Iyer, Professor of Medicine at the MD Anderson Cancer Center. These speakers will cover the agenda topics shown on this slide.

Before we begin, please note that during the course of this presentation and question-and-answer session, we will be making forward-looking statements regarding future events, performance, plans, expectations and other projections, including those relating

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot